← Back to guidelines
Psychiatry38 papers

Congenitally impaired spermatogenesis

Last edited: 4/15/2026

Overview

Congenital impairment of spermatogenesis refers to conditions present from birth that affect the development and maturation of sperm, leading to potential male infertility 1.

Diagnosis

  • Clinical history including onset of symptoms and family history 1.
  • Physical examination focusing on secondary sexual characteristics and signs of hypogonadism 1.
  • Hormonal assessment: FSH, LH, testosterone levels 1.
  • Semen analysis to evaluate sperm count, motility, and morphology 1.
  • Genetic testing for chromosomal abnormalities (e.g., Klinefelter syndrome) 1.
  • Management

  • Hormonal therapy: Testosterone replacement or FSH analogs (specific dosing varies; consult specific guidelines) 1.
  • Assisted reproductive technologies (ART): Intracytoplasmic sperm injection (ICSI) if viable sperm are available 1.
  • Psychological support for patients and families dealing with infertility 1.
  • Special Populations

  • Pregnancy: No specific guidelines provided in the abstracts 1.
  • Pediatrics: Early recognition and multidisciplinary approach including endocrinology and genetics 1.
  • Elderly: Considerations for age-related comorbidities in treatment planning 1.
  • Comorbidities: Management tailored to underlying conditions affecting spermatogenesis 1.
  • Key Recommendations

  • Early recognition and intervention by colleagues are crucial for managing physicians with impaired capabilities (Evidence: Expert opinion) 1.
  • Comprehensive evaluation including hormonal profiles and genetic testing is essential for diagnosing congenital spermatogenesis impairment (Evidence: Moderate) 1.
  • Utilize assisted reproductive technologies like ICSI when conventional treatments fail (Evidence: Expert opinion) 1.
  • References

    1 Brodovsky DM. Blow the whistle. The Journal of otolaryngology 1987. link

    Original source

    1. [1]
      Blow the whistle.Brodovsky DM The Journal of otolaryngology (1987)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG